ETON — Eton Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $424.25m
- $439.13m
- $39.01m
- 29
- 15
- 83
- 37
Annual balance sheet for Eton Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 21.3 | 14.4 | 16.3 | 21.4 | 14.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.048 | 5.47 | 1.85 | 3.41 | 5.36 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 24.7 | 23.6 | 20 | 26.8 | 41 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1 | 0.219 | 0.26 | 0.15 | 0.209 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 26.3 | 27.5 | 25 | 31.7 | 76.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 3.79 | 4.56 | 6.46 | 16.2 | 19.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.7 | 9.84 | 12 | 16.3 | 51.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 15.7 | 17.6 | 13.1 | 15.5 | 24.4 |
| Total Liabilities & Shareholders' Equity | 26.3 | 27.5 | 25 | 31.7 | 76.1 |
| Total Common Shares Outstanding |